Japanese Pharmaceuticals & Biotech Top Dividend Payers

Kissei Pharmaceutical

Market Cap: JP¥190.7b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Santen Pharmaceutical

Market Cap: JP¥543.6b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Astellas Pharma

Market Cap: JP¥4.4t

Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Tsumura

Market Cap: JP¥287.4b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

Daito PharmaceuticalLtd

Market Cap: JP¥43.6b

Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.

Fuji Pharma

Market Cap: JP¥59.1b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Astena Holdings

Market Cap: JP¥19.5b

Manufactures and sells medicine-related products in Japan.

Zeria Pharmaceutical

Market Cap: JP¥92.4b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

Sawai Group Holdings

Market Cap: JP¥252.9b

Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.

Takeda Pharmaceutical

Market Cap: JP¥9.3t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Eisai

Market Cap: JP¥1.4t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals.

Linical

Market Cap: JP¥7.2b

A global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide.

Nippon Shinyaku

Market Cap: JP¥351.9b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.3t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥64.9b

Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.

Kaken Pharmaceutical

Market Cap: JP¥162.6b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.